Goodwin Procter advised Centerview Partners on the deal, Latham & Watkins represented Imago BioSciences, Gibson Dunn & Crutcher advised Merck.Merck (NYSE: MRK) and Imago BioSciences, Inc. (Nasdaq:…
Merck’s $1.35 Billion Acquisition of Imago BioSciences, Inc.
